{"doi":"10.1053/gast.2003.50016","title":"Model for end-stage liver disease (MELD) and allocation of donor livers","abstract":null,"journal":"Gastroenterology","year":2003,"id":29237,"datarank":24.353514780579896,"base_score":7.83241092718792,"endowment":7.83241092718792,"self_citation_contribution":1.174861639078188,"citation_network_contribution":23.17865314150171,"self_endowment_contribution":1.174861639078188,"citer_contribution":23.17865314150171,"corpus_percentile":null,"corpus_rank":null,"citation_count":2520,"citer_count":200,"citers_with_citation_signal":200,"citers_with_endowment":200,"datacite_reuse_total":14,"is_dataset":false,"is_dataset_confidence":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":161691,"name":"Erick Edwards","orcid":null,"position":1,"is_corresponding":false},{"id":161692,"name":"Richard Freeman","orcid":null,"position":2,"is_corresponding":false},{"id":161693,"name":"Ann Harper","orcid":null,"position":3,"is_corresponding":false},{"id":161694,"name":"Ray Kim","orcid":null,"position":4,"is_corresponding":false},{"id":161695,"name":"Patrick Kamath","orcid":null,"position":5,"is_corresponding":false},{"id":161696,"name":"Walter Kremers","orcid":null,"position":6,"is_corresponding":false},{"id":161697,"name":"John Lake","orcid":null,"position":7,"is_corresponding":false},{"id":161698,"name":"Todd Howard","orcid":null,"position":8,"is_corresponding":false},{"id":161699,"name":"Robert M. Merion","orcid":null,"position":9,"is_corresponding":false},{"id":161700,"name":"Robert A. Wolfe","orcid":null,"position":10,"is_corresponding":false},{"id":161701,"name":"Ruud Krom","orcid":null,"position":11,"is_corresponding":false},{"id":161690,"name":"Russell Wiesner","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":7.83241092718792,"endowment":7.83241092718792,"datacite_reuse_total":14,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"12512033","pmcid":null,"openalex_id":"https://openalex.org/W2140396673","authors":[],"funders":[],"total_grants":0,"fwci":38.6828,"citation_percentile":0.99955102,"influential_citations":88,"citation_trend":[{"year":2012,"count":121},{"year":2013,"count":117},{"year":2014,"count":131},{"year":2015,"count":125},{"year":2016,"count":127},{"year":2017,"count":136},{"year":2018,"count":146},{"year":2019,"count":136},{"year":2020,"count":141},{"year":2021,"count":126},{"year":2022,"count":120},{"year":2023,"count":117},{"year":2024,"count":104},{"year":2025,"count":64},{"year":2026,"count":32}],"oa_status":"bronze","license":"https://www.elsevier.com/tdm/userlicense/1.0/","oa_locations":[{"url":"http://www.gastrojournal.org/article/S0016508503500221/pdf","host_type":"journal"},{"url":"http://www.gastrojournal.org/article/S0016508503500221/pdf","host_type":"BRONZE"},{"url":"http://www.gastrojournal.org/article/S0016508503500221/pdf","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0016508503500221?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0016508503500221?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1053/gast.2003.50016","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/12512033","host_type":"repository"}],"fields_of_study":["Liver Disease and Transplantation","Organ Transplantation Techniques and Outcomes","Liver Diseases and Immunity","Medicine"],"mesh_terms":["Adult","Aged","Female","Forecasting","Humans","Male","Middle Aged","Severity of Illness Index","Waiting Lists","Cohort Studies","Liver Transplantation","Liver Failure","Resource Allocation"],"keywords":["Model for End-Stage Liver Disease","Medicine","Liver disease","Internal medicine","Cirrhosis","Chronic liver disease","Liver transplantation","Gastroenterology","Mortality rate","Cohort","Receiver operating characteristic","Creatinine","Surgery","Transplantation"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[{"doi":"10.6084/m9.figshare.14100753.v1","title":"Additional file 1 of Risk indices predicting graft use, graft and patient survival in solid pancreas transplantation: a systematic review","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14100753","title":"Additional file 1 of Risk indices predicting graft use, graft and patient survival in solid pancreas transplantation: a systematic review","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.19776326.v1","title":"Additional file 1 of The assessment of mesenchymal stem cells therapy in acute on chronic liver failure and chronic liver disease: a systematic review and meta-analysis of randomized controlled clinical trials","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.19776326","title":"Additional file 1 of The assessment of mesenchymal stem cells therapy in acute on chronic liver failure and chronic liver disease: a systematic review and meta-analysis of randomized controlled clinical trials","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.19776329.v1","title":"Additional file 2 of The assessment of mesenchymal stem cells therapy in acute on chronic liver failure and chronic liver disease: a systematic review and meta-analysis of randomized controlled clinical trials","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.19776329","title":"Additional file 2 of The assessment of mesenchymal stem cells therapy in acute on chronic liver failure and chronic liver disease: a systematic review and meta-analysis of randomized controlled clinical trials","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.22625959.v1","title":"Additional file 1 of Impact of race-independent equations on estimating glomerular filtration rate for the assessment of kidney dysfunction in liver disease","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.22625959","title":"Additional file 1 of Impact of race-independent equations on estimating glomerular filtration rate for the assessment of kidney dysfunction in liver disease","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.25310127.v1","title":"Additional file 1 of Revising model for end-stage liver disease from calendar-time cross-sections with correction for selection bias","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.25310127","title":"Additional file 1 of Revising model for end-stage liver disease from calendar-time cross-sections with correction for selection bias","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26610531.v1","title":"Additional file 1 of Continuous passive paracentesis versus large-volume paracentesis in the prevention and treatment of intra-abdominal hypertension in the critically ill cirrhotic patient with ascites (COPPTRIAHL): study protocol for a randomized controlled trial","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26610531","title":"Additional file 1 of Continuous passive paracentesis versus large-volume paracentesis in the prevention and treatment of intra-abdominal hypertension in the critically ill cirrhotic patient with ascites (COPPTRIAHL): study protocol for a randomized controlled trial","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26610534.v1","title":"Additional file 2 of Continuous passive paracentesis versus large-volume paracentesis in the prevention and treatment of intra-abdominal hypertension in the critically ill cirrhotic patient with ascites (COPPTRIAHL): study protocol for a randomized controlled trial","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26610534","title":"Additional file 2 of Continuous passive paracentesis versus large-volume paracentesis in the prevention and treatment of intra-abdominal hypertension in the critically ill cirrhotic patient with ascites (COPPTRIAHL): study protocol for a randomized controlled trial","publisher":"figshare","resource_type":"JournalArticle"}],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-08T22:56:08.241588Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}